Glutathione is the anchor for brightening: the bodys master antioxidant inhibits tyrosinase, the enzyme that drives melanin production, which is the mechanism behind its use as a brightening and antioxidant support, not a disease treatment
Arias-Chvez DJ, Mailloux-Salinas P, Ledesma-Aparicio J, Campos-Prez E, Medina-Campos ON, Pedraza-Chaverri J, et al
A Canadian population-based cohort study by Leon et al showed that, in Ontario, stopping RAASi therapy increased the risks of both overall death and need for dialysis [5]
thus, these findings should be approached with caution, and more clinical trials on its efficacy and safety should be conducted
Emphasis will be placed on the metabolic pathways and relevant players (Table 1) that interfere with cysteine anabolism and catabolism, and the determinants that affect cysteine bioavailability, thereby influencing cancer development